The pro-proliferative role of Tsg101 itself appears to extend to tumor cells as a reduction of Tsg101 protein by siRNA had a negative impact on tumor cell growth (Zhu et al., 2004) and compromised the MAPK/ERK signal pathway in breast cancer cells (Zhang et al., 2011). This evidence concerns the gene TSG101 and breast cancer.